Literature DB >> 30765440

Ergometrine-induced atrial fibrillation at caesarean section.

Samuel Birch1, Corrine Lu2.   

Abstract

A 36-year-old woman with a history of one previous caesarean section presented to the birthing suite of a regional hospital with spontaneous rupture of membranes at 39+2/40 weeks. Syntocinon was administered to initiate uterine contractions in the absence of labour, as the patient desired vaginal birth. A caesarean section was subsequently indicated and ergometrine was administered for uterine atony. The patient immediately developed atrial fibrillation (AF). AF is the most common sustained arrhythmia in the general population, but is rare in the obstetric population. AF occurring in an intrapartum setting following the administration of syntocinon and ergometrine, is not documented in the literature. We suggest the initiation of paroxysmal AF was precipitated by an abrupt alteration in autonomic tone caused by administration of syntocinon followed by ergometrine. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arrhythmias; drugs: obstetrics and gynaecology

Mesh:

Substances:

Year:  2019        PMID: 30765440      PMCID: PMC6381988          DOI: 10.1136/bcr-2018-226747

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  26 in total

1.  Estimating the current and future prevalence of atrial fibrillation in the Australian adult population.

Authors:  Jocasta Ball; David R Thompson; Chantal F Ski; Melinda J Carrington; Tracey Gerber; Simon Stewart
Journal:  Med J Aust       Date:  2015-01-19       Impact factor: 7.738

2.  Ventricular ectopic activity following intravenous ergometrine.

Authors:  T W Baillie
Journal:  Anaesthesia       Date:  1969-04       Impact factor: 6.955

3.  The influence of ergometrine on the initiation of cardiac impulse.

Authors:  T W Baillie
Journal:  J Obstet Gynaecol Br Commonw       Date:  1969-01

4.  Cardiac effects of oxytocin: is there a role for this peptide in cardiovascular homeostasis?

Authors:  R H Costa-E-Sousa; P P Pereira-Junior; P F Oliveira; E L Olivares; J P S Werneck-de-Castro; D B Mello; J H M Nascimento; A C Campos-de-Carvalho
Journal:  Regul Pept       Date:  2005-10-06

5.  Atrial fibrillation in pregnancy.

Authors:  Lt Angela DiCarlo-Meacham; Lcdr Joshua Dahlke
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

Review 6.  Epidemiology of Atrial Fibrillation: The Australian and Asia-Pacific Perspective.

Authors:  Christopher X Wong; Alex Brown; Hung-Fat Tse; Christine M Albert; Jonathan M Kalman; Thomas H Marwick; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Lung Circ       Date:  2017-05-24       Impact factor: 2.975

7.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

Review 8.  Cardiac Arrhythmias and Pregnancy.

Authors:  Ciorsti MacIntyre; Chinyere Iwuala; Ratika Parkash
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-07-11

9.  Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.

Authors:  Nicola Jaime Adderley; Ronan Ryan; Krishnarajah Nirantharakumar; Tom Marshall
Journal:  Heart       Date:  2018-07-10       Impact factor: 5.994

10.  Ventricular tachycardia observed during cesarean section in a patient without structural cardiac disease.

Authors:  Mika Nakanishi; Kaoru Masumo; Takako Oota; Takeshi Kato; Toshihiro Imanishi
Journal:  JA Clin Rep       Date:  2015-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.